When Is Gyn Onc Discussion Reasonable for Elevated CA-125?

Quick answer

CA-125 Referral

• CA-125 alone is usually not a tissue diagnosis or standalone consult reason.
• CA-125 becomes more actionable with high-risk imaging, concerning exam, menopausal status, symptoms, or pathology. [2]
• Workup-first cases need imaging, exam, sampling, records, or contextual labs before Gyn Onc can answer the right question.

Gyn Onc discussion is reasonable when

Actionable CA-125 Context

• Elevated CA-125 plus high-risk adnexal imaging or metastatic pattern. [1][2]
• Elevated CA-125 plus confirmed gynecologic malignancy.
• The consult question is staging, oncologic surgery, neoadjuvant therapy, biopsy route, or disposition.

Workup usually comes first when

Better First Step

• CA-125 is elevated without high-risk imaging or tissue diagnosis.
• There are plausible non-malignant explanations and the next step is risk stratification.
• The question is whether a lab is abnormal, not what oncologic decision changes today.

Common pitfall

A Tumor Marker Is Not a Diagnosis

CA-125 is context. The consult gets cleaner when paired with imaging, exam, pathology, or a specific decision Gyn Onc can change.

Before you consult

Make the Marker Actionable

• Confirm why CA-125 was checked and whether there is adnexal imaging, concerning exam, symptoms, menopausal context, or pathology.
• If the patient is stable and the consult question is only an isolated lab abnormality, imaging or standard gynecology workup is usually the better first step.
• Bring Gyn Onc a decision they can answer: biopsy route, staging, admission service, transfer, oncologic-surgery question, treatment-planning pathway, or outpatient timing.